Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2024-11-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement of Sarcopenia in Patients Following Two Different Diets
NCT03405727
Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia
NCT02374268
Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia
NCT00748696
Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program
NCT03417531
Lifestyle Modifications for the Treatment of Sarcopenic Obesity
NCT02379026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mediterranean diet
Mediterranean diet and physical exercise
Mediterranean diet
Mediterranean diet recommendations and daily physical exercise
Vitamin D supplementation
Calcifediol supplement administered orally in order to reach sufficiency levels (30 ng/ml)
Physical exercise
Physical exercise adapted to patients with heart failure (Cardiac rehabilitation)
Standard hypercaloric hyperproteic Oral supplement
Standard hypercaloric hyperproteic oral supplement plus Mediterranean diet and physical exercise
Mediterranean diet
Mediterranean diet recommendations and daily physical exercise
Hypercaloric, hyperproteic oral nutritional supplement
Hypercaloric, hyperproteic oral supplement combined with Mediterranean diet recommendations (2 per day) and daily physical exercise
Vitamin D supplementation
Calcifediol supplement administered orally in order to reach sufficiency levels (30 ng/ml)
Physical exercise
Physical exercise adapted to patients with heart failure (Cardiac rehabilitation)
Protein module
Protein module (10g/day) plus Mediterranean diet and physical exercise
Mediterranean diet
Mediterranean diet recommendations and daily physical exercise
Protein module
Protein module (10g/day) combined with Mediterranean diet recommendations and daily physical exercise
Vitamin D supplementation
Calcifediol supplement administered orally in order to reach sufficiency levels (30 ng/ml)
Physical exercise
Physical exercise adapted to patients with heart failure (Cardiac rehabilitation)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mediterranean diet
Mediterranean diet recommendations and daily physical exercise
Hypercaloric, hyperproteic oral nutritional supplement
Hypercaloric, hyperproteic oral supplement combined with Mediterranean diet recommendations (2 per day) and daily physical exercise
Protein module
Protein module (10g/day) combined with Mediterranean diet recommendations and daily physical exercise
Vitamin D supplementation
Calcifediol supplement administered orally in order to reach sufficiency levels (30 ng/ml)
Physical exercise
Physical exercise adapted to patients with heart failure (Cardiac rehabilitation)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate or severe LVEF
* Both sexs
* Age \>18 years old.
Exclusion Criteria
* End-stage liver disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maimónides Biomedical Research Institute of Córdoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IMIBIC
Córdoba, Cordoba, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Insuficiencia cardiaca 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.